Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study-Reference-Cited by-同舟云学术

Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study

Published:2010-12 Issue:12 Volume:11 Page:1142-1148
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Gruenberger Birgit,Schueller Johannes,Heubrandtner Ute,Wrba Fritz,Tamandl Dietmar,Kaczirek Klaus,Roka Rudolf,Freimann-Pircher Sandra,Gruenberger Thomas

Publisher

Elsevier BV

Subject

Oncology

Reference41 articles.

1. The epidemiology of cholangiocarcinoma;Shaib;Semin Liver Dis,2004

2. A review and update on cholangiocarcinoma;Olnes;Oncology,2004

3. Cholangiocarcinoma;Khan;Lancet,2005

4. Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma;Tamandl;Ann Surg Oncol,2008

5. Cancer statistics, 2009;Jemal;CA Cancer J Clin,2009

Cited by 209 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment Response and Survival with Chemotherapy for Unresectable, Nonmetastatic Cholangiocarcinoma;Euroasian journal of hepato-gastroenterology;2024-06-12

2. Advances in targeted therapy of cholangiocarcinoma;Annals of Medicine;2024-02-15

3. Perioperative and palliative systemic treatments for biliary tract cancer;Therapeutic Advances in Medical Oncology;2024-01

4. Research Progress in Targeted Therapy for Cholangiocarcinoma;Advances in Clinical Medicine;2024

5. Utilization of Radiomics Features Extracted From Preoperative Medical Images to Detect Metastatic Lymph Nodes in Cholangiocarcinoma and Gallbladder Cancer Patients: A Systemic Review and Meta-analysis;Journal of Computer Assisted Tomography;2023-11-27